Synergy CHC Corp. (NASDAQ:SNYR) Short Interest Down 50.3% in July

Synergy CHC Corp. (NASDAQ:SNYR) saw a large decline in short interest in the month of July. As of July 15th, there was short interest totaling 79,207 shares, a decline of 50.3% from the June 30th total of 159,367 shares. Based on an average daily volume of 208,861 shares, the short-interest ratio is currently 0.4 days. Approximately 0.8% of the shares of the company are sold short.

Institutional Investors Weigh In On Synergy CHC

A number of institutional investors have recently bought and sold shares of the stock. Geode Capital Management LLC raised its stake in Synergy CHC by 29.9% during the fourth quarter. Geode Capital Management LLC now owns 36,038 shares of the company’s stock worth $67,000 after purchasing an additional 8,288 shares during the period. Virtu Financial LLC purchased a new stake in shares of Synergy CHC during the 3rd quarter valued at $38,000. DRW Securities LLC purchased a new stake in shares of Synergy CHC during the 4th quarter valued at $36,000. Finally, XTX Topco Ltd purchased a new stake in shares of Synergy CHC during the 2nd quarter valued at $57,000.

Synergy CHC Price Performance

SNYR traded up $0.00 during midday trading on Tuesday, reaching $0.17. 31,929 shares of the company’s stock were exchanged, compared to its average volume of 1,703,102. Synergy CHC has a 1-year low of $0.16 and a 1-year high of $3.99. The stock has a market capitalization of $2.57 million, a PE ratio of -0.12 and a beta of -0.14. The business’s 50-day moving average price is $0.21 and its 200 day moving average price is $0.84.

Synergy CHC (NASDAQ:SNYR) last released its earnings results on Thursday, May 14th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.26). The business had revenue of $5.49 million for the quarter. As a group, analysts expect that Synergy CHC will post -0.19 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts have recently commented on SNYR shares. Zacks Research cut Synergy CHC from a “hold” rating to a “strong sell” rating in a report on Friday, June 12th. Ascendiant Capital Markets upped their price objective on Synergy CHC from $5.00 to $5.50 and gave the stock a “buy” rating in a report on Tuesday, April 14th. Finally, Weiss Ratings upgraded Synergy CHC from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, June 29th. Two equities research analysts have rated the stock with a Buy rating and two have given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $6.25.

About Synergy CHC

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.